SAMANTHA PERKINS: Open Payments
NPI 1790023281 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,275 in 171 payments from 8 companies in 2025. Trend: 2023 $1,457 · 2024 $14,905 · 2025 $32,275
Speaker / faculty: $24,172Travel & lodging: $4,182Food & beverage: $3,812Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 129 | $31,463 |
| Alkermes, Inc. | 14 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $210 |
| E.R. Squibb & Sons, L.L.C. | 13 | $186 |
| Luye Pharma (USA) Ltd. | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Neuronetics, Inc. | 1 | $19 |
Products named: UZEDY, CAPLYTA, ARISTADA, COBENFY, ERZOFRI EXTENDED-RELEASE, SPRAVATO, VIVITROL, REXULTI.
Industry payments across CA — which companies pay providers there.
